Login / Signup

Durability of complete response after blinatumomab therapy for relapsed/refractory diffuse large B-cell lymphoma.

Andreas ViardotGeorg HessRalf C BargouNicholas J MorleyGiuseppe GrittiMaria-Elisabeth GoebelerKarim IskanderDavid CohanAlicia ZhangJanet FranklinLuke Coyle
Published in: Leukemia & lymphoma (2020)
Keyphrases
  • diffuse large b cell lymphoma
  • acute lymphoblastic leukemia
  • epstein barr virus
  • acute myeloid leukemia
  • multiple myeloma
  • hodgkin lymphoma